3,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazine, 97%, 100mg

(3R,4S,5S,7aR)-3,5,6,7a-Tetramethyl-1-oxo-N,N-diphenyl-1,3,3a,4,5,7a-hexahydroisobenzofuran-4-carboxamide, 97%, 25mg

2-(2-Benzoxazolyl)malondialdehyde, 95.0%, 10g

Y6-BO-4F, 98%, 100mg

Triisobutylene (mixture of branched chain isomer)>90.0%(GC)25mL

(4S,4'S)-2,2'-Methylenebis[4,5-dihydro-4-(phenylmethyl)oxazole], 97%, 1g

4,5-Dichloro-2H-pyridazin-3-one, 97.0%, 10g

2-Bromo-4-hexylthiophene>98.0%(GC)1g

p-Nitrophenyl phosphate di(tris) salt, >90.0%(T), 1g

(5S,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-17-((R)-6-methylheptan-2-yl)tetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, 97%, 1g

(2E)-1-(3-chlorophenyl)-3-(3-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 2g

2-(2-Pyridyl)ethyltrimethoxysilane, 97%, 1g

1-Cbz-2-Hydroxymethylpiperidine, 95.0%, 5g